MedPath

Pre-treatment with Mifepristone prior to Mirena insertion for optimizing bleeding pattern in pre-menopausal women - mifepristone prior to Mirena

Conditions
The main objective of the present study is to study the effect of pre-treatment with Mifegyne in pre-menopausal women requesting Mirena for contraception in order to imrpove bleeding pattern during the initial months of Mirena treatment.
Registration Number
EUCTR2009-009014-40-SE
Lead Sponsor
Karolinska Institutet
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

•Pre-menopausal women, >/= 18 years of age.
•Desire of Mirena for contraception
•Good general health
•Willing and able to participate after giving informed consent

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years)
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

•Any hormonal treatment or IUD use within 2 months prior to study start
•History of malignant disorder of the breast
•Any contraindication to mifepristone
•Pregnancy or breast feeding within 2 months prior to study start

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath